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ABSTRACT
Lower gastrointestinal bleeding (LGIB) is associated with high morbidity and mortality. Embolization is currently
proposed as the first step in the treatment of acute, life-threatening LGIB, when endoscopic approach is not possible or is
unsuccessful. Like most procedures performed in emergency setting, time represents a significant factor influencing
outcome. Modern tools permit identifying and reaching the bleeding site faster than two-dimensional angiography. Non-
selective cone-beam CT arteriography can identify a damaged vessel. Moreover, sophisticated software able to detect
the vessel may facilitate direct placement of a microcatheter into the culprit vessel without the need for sequential
angiography. A further important aspect is the use of an appropriate technique of embolization and a safe and effective
embolic agent. Current evidence shows the use of detachable coils (with or without a triaxial system) and liquid embolics
has proven advantages compared with other embolic agents. The present article analyses these modern tools, making
embolization of acute LGIB safer and more effective.
KEY POINTS
– To describe new tools available to facilitate endovascular
treatment of lower gastrointestinal bleeding (LGIB).
– To suggest to interventional radiologists how best to
manage procedures to increase safety and to reduce non-
target embolization.
INTRODUCTION
LGIB is deﬁned as bleeding distal to the ligament of the
Treitz. The incidence is approximately 36 per 1,00,000
population,1 and it is associated with signiﬁcant mor-
bidity and mortality. Most cases are self-limited in el-
derly population and may be approached medically by
correction of coagulation or endoscopy. Patients with
signiﬁcant bleeding for which these methods fail are
candidates for endovascular treatment before surgical
treatment.1
First, radiological and nuclear medicine methods can be
extremely useful for the diagnosis. Scintigraphy is a con-
solidated method in the identiﬁcation of obscure gastro-
intestinal bleeding. On the basis of literature data, the
reported success rates for detecting exact locations of
bleeding range from 19% to 96%.
In future, correlation with further diagnostic tests such as
capsule endoscopy and double-balloon enteroscopy scin-
tigraphy is necessary.2
Multidetector CT angiography (CTA), using the correct
protocol, is able to detect bleeding from an amount of
;0.3mlmin21, to depict surrounding anatomical struc-
tures and to determine not only the place, but also the
possible cause of bleeding; for this reason, multidetector
CT became the diagnostic method of choice in massive
LGIB, where colonoscopy is not useful or cannot be
performed.3,4
In addition, CTA can be used as a suitable selection agent
for angiographic intervention,5,6 allowing avoidance of the
extra risks associated with this invasive technique.1,5 It can
allow for pre-assessment of differences in a patient’s partic-
ular vascular anatomy, and it makes subsequent vessel se-
lection easier for embolization during formal angiography.1,5
The indication for the procedure of embolization is usually
based on a multidisciplinary consensus between the gas-
troenterologist, radiologist and surgeon. In particular,
endovascular embolization is an established treatment for
managing patients who are haemodynamically unstable or
patients who are stabilized with ﬂuid resuscitation.1,7
Surgical treatment is considered suitable in patients with
bleeding gastroduodenal peptic ulcer or recurrent bleeding from
colonic diverticula and after endoscopy and embolization ther-
apy failure.
Contraindications to embolization are relative, generally related
to general contraindications for iodine-contrast examinations
(allergy and renal insufﬁciency).7
In view of the criticality of the patients who arrive in the an-
giographic suite, the procedure of embolization requires great
care and attention, and it must be performed in the shortest
possible time, using the most appropriate device to prevent non-
target embolization.
Below, we analyse these two important topics: imaging guidance
and safe embolization.
Advances in imaging guidance
Accurate and prompt identiﬁcation of the bleeding site during the
treatment session is fundamental for timely control of haemorrhage.
However, procedures are sometimes challenging even for skilled
operators and require several sequential angiographic runs for
the manual identiﬁcation of the leaking artery on two-
dimensional angiographic images.
Nowadays, software to facilitate and improve procedure are
available. In particular, cone-beam CT (CBCT) capable of
providing more information than standard two-dimensional
angiography in localizing and/or visualizing target vessel and
subsequently reach it.8
Identifying the speciﬁc artery responsible for the bleeding is
difﬁcult, when the arterial vasculature has a complex branching
pattern.
CBCT is performed with a catheter in a principal vessel (supe-
rior or inferior mesenteric artery), using correct parameters (in
terms of amount and ﬂow), for the injection of contrast me-
dium. The protocol described below is used in our angiographic
suite (Allura Xper FD20; Philips Healthcare, Best, Netherlands).
Depending on the catheter/microcatheter tip location, dual-phase
cone-beam CT (DP-CBCT) may be obtained. Different volume of
contrast medium and ﬂow rate may be used. Pressure limit is
usually 900psi, but when the microcatheter tip is located in a very
small vessel (,3-mm diameter), a pressure of 600 psi is chosen.
When a catheter is used, a volume of 10–60ml of non-diluted
contrast medium may be injected (300mg of iodine per milli-
litre) (for example, 10ml in a branch of the mesenteric artery,
40ml in the mesenteric artery and 60ml in the abdominal aorta
above the carrefour), with a ﬂow rate that is adapted to the
selected arterial district, ranging from 1 to 6ml s21; if a micro-
catheter is used, a volume of 5–20ml of non-diluted contrast
medium may be injected, with a ﬂow rate adapted to the selected
arterial district, ranging from 1 to 5ml s21. In both cases, a delay
time before imaging must be considered, according to the du-
ration of acquisition. Delayed-phase CBCTmay be triggered 15 s
after the end of the ﬁrst CBCT scan in order to identify late
Figure 1. Dual-phase non-selective cone-beam CT arteriography performed with a catheter in the superior mesenteric artery (a–d).
First acquisition revealing active arterial bleeding in the caecum (arrow) (a); delayed second acquisition showing accumulation of
contrast medium in the lumen (arrow) (b); coronal view showing afferent vessels to the bleeding (arrow) (c); accumulation of
contrast medium in the lumen (arrow) documented by second acquisition: coronal view (d).
BJR Ierardi et al
2 of 7 birpublications.org/bjr Br J Radiol;89:20150934
enhancing bleedings. Breathing artefacts may be avoided, asking
patients to hold their breath or breathe shallowly, whenever
possible. The volumetric data sets are automatically transferred
to a three-dimensional (3D) workstation (XtraVision 8.8; Philips
Healthcare), where 3D reconstruction may be performed and
displayed as cross-sectional images. When the bleeding site is
identiﬁed, automatic vessel detection (AVD) software (Embo-
Guide; Philips Healthcare) is used to determine the most ap-
propriate arterial route leading to the haemorrhage. The AVD
software applies a minimal path using a “segmentation” of the
Figure 2. The software permits “segmentation” of the bleeding site (white arrow) and a starting point, normally the catheter tip (blue
arrow): all the afferent vessels were detected (a). Arterial route determined using the software could be overlaid on live fluoroscopy
and exploited during the intervention to facilitate catheter navigation to the damaged vessel (b).
Figure 3. Preliminary non-selective angiography of an uncooperative patient (a): bleeding is documented (arrow) but the culprit
vessel is not clear. Non-selective cone-beam CT angiography was performed (b): automated vessel detection was not applied
because of breathing artefacts, but the operator intuited the feeder (short arrow) of the bleeding site (arrow). Selective
catheterization of that vessel confirmed bleeding (arrow) (c); final angiogram performed with detachable microcoil (d).
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bleeding site and a starting point, normally the catheter tip. If the
bleeding site was not correctly depicted on DP-CBCT images, CTA
data sets could be imported into the 3D workstation and
CBCT–CT fusion can be performed: target segmentation may be
performed on the CTA data set. Once the target culprit artery is
reached, a selective angiogram is performed to conﬁrm correct
position9 (Figure 1a–d).
The application described should reduce the number of image
acquisitions and overall procedure time, because the software can
identify a damaged vessel from non-selective CBCT arteriography
images and facilitate direct placement of a microcatheter into the
culprit vessel without the need for sequential angiography.8,9
Further, the software visualizes the arterial path from the cath-
eter tip to the target site on a 3D vascular map at the optimal
working angle, enabling easier, quicker and more accurate target
catheterization (Figure 2a,b).
When multiple bleeding sites are present, each leaking artery
could be determined from a single acquisition of a non-selective
CBCT image, during contrast injection of the proximal artery.
Multiple software processes are necessary to detect the artery
responsible for each bleeding site.
Since volumetric CBCT data sets are acquired in a calibrated co-
ordinate space and are synchronized with the C-arm, ﬂat-panel
detector and angiographic table displacements, the arterial
route determined using the software could be overlaid on live
ﬂuoroscopy and exploited during intervention, to facilitate
catheter navigation to the damaged vessel (Figure 2b).
One limitation could be the increased susceptibility of C-arm CT to
patient motion compared with conventional CT. Even transient
movement during image acquisition negatively affects the quality of
the entire image, resulting in risk of misinterpretation.9,10 However,
in our experience, the combination with the AVD software helps in
the interpretation of the CBCT data set and provides the correct
path to the bleeder also in the case of mild motion artefacts
(Figure 3a–d).
Moreover, in some cases, previous CTA data sets could be imported
into the 3D workstation, and target segmentation may be per-
formed on the basis of the CTA data set after CBCT–CT fusion.
Some authors reported as limitation the ﬁeld of view, but in our
opinion, in accordance with preliminary experience,9,10 contrast-
enhanced C-arm CT is performed with the catheter in the superior
or inferior mesenteric artery and the ﬁeld of view is selected on the
basis of previous CT; in particular, if the bleeding is localized in the
ascending colon, C-arm CT is aimed to the study of that region:
ﬁeld of view is enough.
These computer software, speciﬁcally designed to assist in
planning embolization, have reported signiﬁcative advantages in
terms of sensitivity for detecting feeders to the target with
a shorter processing time (;2min) than manual angiographic
assessments.10
Figure 4. Contrast-enhanced CT revealed arterial bleeding of a diverticulum (arrow) of the descending colon previously treated
endoscopically (a); coronal view of the contrast-enhanced CT showing the bleeding (arrow) (b); angiography performed after
super-selective catheterization of the vasa recta near clips, confirmed bleeding (arrow) (c); final angiogram of the inferior
mesenteric artery revealed complete embolization and detachable microcoil (arrow) in the bleeder (d).
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The feasibility and utility of CBCT and vessel-tracking software
has primarily been proven in targeted chemoembolization of
liver malignancies and benign prostate hyperplasia, with
a reported detection accuracy of around 90% in detecting
feeding branches.8–10 Iwazawa and Carraﬁello reported ﬁrst
experiences in emergency transarterial embolization.9,10
On the basis of the data reported above, the use of angiographic
CBCT and AVD software during embolization of arterial
bleedings can improve operator conﬁdence with embolization
techniques in emergency settings, reduce overall procedural time
and total contrast media administration and ultimately have an
impact on treatment outcome.
Advances in embolotherapy
The second aspect in which improvements are available is em-
bolization technique and tools. Embolization may be performed
with gelatin sponges; particles; coils; and microcoils; and, more
recently, glue. There are no guidelines for the choice of embolic
material used, and the ﬁnal decision is usually made by the operator
on the basis of his experience and compliance. There are two main
concerns with LGIB embolization. Rebleeding after endoscopy or
embolization of LGIB is a key point and it has been described to be
as high as 25%. Rebleeding has an impact on the outcome and is
a negative-predictive factor for survival.11 The second main concern
in LGIB embolization is the risk of secondary bowel ischaemia
because bowel irrigation is terminal with no collateral circulation; so,
embolization must be very accurate at the bleeding site, and non-
target embolization should always be avoided.
The goal is to embolize selectively at the level of the vasa recta,
avoiding the marginal artery; some authors suggested less-
selective ﬂow-directed particle embolization.12 However, the
particles are associated with an increased risk of bowel infarction
because they cannot be visualized or precisely deposited and may
reﬂux into non-target arteries. Cyanoacrylates are very effective
Figure 5. Contrast-enhanced CT revealed arterial bleeding of the colonic angiodysplasia (arrows) (a–f). Axial (a) and coronal (b) view; non-
selective cone-beam CT arteriography showing the bleeder (arrow) (c); angiography performed after super-selective catheterization
of the feeder that reveals the bleeding (arrow) (d); final angiogram performed after embolization with Onyx (e); plain image showing
the Onyx distribution in the previous bleeding site (f).
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in terms of bleeding control and rebleeding but are not con-
trollable and require high operator expertise otherwise their use
is associated with high risk of non-targeted embolization and
severe intestinal ischaemia.13 Another potential risk related to
cyanoacrylates is microcatheter entrapment.12,13
For this purpose, in most centres, detachable coils were in-
troduced,14 sometimes using a triaxial system.14 Vessels may
sometimes be too thin and/or tortuous and, super-selective
catheterization can still be difﬁcult to perform safely. Shimohira
et al14 indicated that the 2.7-Fr microcatheter provides good
support for the 1.9-Fr non-tapered microcatheter to advance
into even thin tortuous vessels. Detachable coils have been
recommended for these situations14 (Figure 4a–d).
Microvascular plug (Medtronic, Irvine, CA) is a new embolic
device, recently introduced, which enables the treatment of
distal, super-selective vessels; but, at the moment, no data are
available for selective embolization of LGIB.
Ethylene-vinyl alcohol copolymer, Onyx® (Medtronic), is in-
creasingly used as embolization agent in peripheral interventional
radiology.15 Ethylene-vinyl alcohol copolymer is a liquid emboliza-
tion agent which is a plastic polymer dissolvable in a potent organic
solvent, dimethyl sulfoxide. It does not have adhesive properties in
contact with arterial walls but only properties of “ﬁlling” the vas-
cular lumen. The major advantages of this liquid compared with
glue are its controlled release, non-adherence, progressive solidiﬁ-
cation, cohesiveness, high vascular penetration and a weak in-
ﬂammatory effect on the endothelium.16 Unlike cyanoacrylates, it
does not polymerize into a block but solidiﬁes gradually from the
periphery out towards the centre.15,16 Onyx® is not carried by blood
ﬂow but is conversely displaced by pressure applied by the operator
on the syringe. This makes the procedure safer, enables the operator
to stop the injection at any time leaving the distal tip of the catheter
in situ and to start again even a few minutes later.
Time is essential in cases of acute arterial haemorrhage. The
bottles need to be shaken for 20min to obtain a consistent
mixture of the tantalum powder. In our experience, it is advis-
able to start stirring Onyx as soon as it is suspected that its use
may be necessary, and if ﬁnally not used, it can be returned to
the shelves to be used another time.12
Coagulopathy is a negative-predictive factor for survival, bleeding
control and rebleeding in patients with LGIB.9,10 Onyx has the
remarkable advantage of acting independently of any underlying
coagulopathy or low platelet count.9,10
On the basis of the characteristics described above, Onyx could
present some advantages in the embolotherapy of LGIB.
Moreover, we never registered ischaemic damage of the bowel
requiring surgery: we hypothized a decrease of blood ﬂow more
than a complete occlusion, especially when Onyx does not make
the cast in the vessel (Figure 5a–f). Clearly, before afﬁrming this
concept, more clinical evidences are necessary.
We described techniques designed to improve procedures of
embolization. In our opinion, early identiﬁcation of the leaking
vessel, fast reaching of the site of bleeding and use of an embolic
agent that reduces risks of non-target embolization and bowel
ischaemia may be considered fundamental for fast and precise
LGIB embolization.
In conclusion, nowadays modern tools for diagnosis and also for
endovascular treatment are available to make embolization of
acute massive LGIB safer and more effective.
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